ArticleCurrent protocols2025
High-Throughput Pipeline for Protein Expression and Solubility Profiling Using Synthetically Generated Plasmids.
Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-Throughput Pipeline for Protein Expression and Solubility Profiling Using Synthetically Generated Plasmids.Current protocols · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-throughput protein expression and purification can now take advantage of the copious expansion of genes from extensive genomics and metagenomic surveillance programs. This article outlines a pipeline that involves strategic selection of a large repertoire of protein targets for cloning by commercial synthetic services, followed by high-throughput transformation, expression, and solubility screening. This pipeline will be applicable to structural and functional genomics approaches, as well as any project that requires large-scale screening for production of soluble proteins in a time-efficient manner. The protocols involve transformation, protein expression and solubility determination in a high-throughput fashion in a 96-well plate format. Proteins screened in this pipeline are then able to be purified for any assay needed. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Target optimization Basic Protocol 2: High-throughput transformation Basic Protocol 3: High-throughput expression and solubility screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.